ERBB2 and breast cancer: When we classified the primary tumors as being ER/PR-positive, triple-negative, and HER2-positive tumors, no association was found between PTEN status (or loss of 10q) and breast cancer subtype, indicating that loss of PTEN is an independent predictor of brain metastases.